These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 36180912)
1. Risk factors for level V metastasis in patients with N1b papillary thyroid cancer. Kang JG; Choi JE; Kang SH World J Surg Oncol; 2022 Sep; 20(1):327. PubMed ID: 36180912 [TBL] [Abstract][Full Text] [Related]
2. Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis. Back K; Kim TH; Lee J; Kim JS; Choe JH; Oh YL; Cho A; Kim JH J Pediatr Surg; 2023 Mar; 58(3):568-573. PubMed ID: 35973863 [TBL] [Abstract][Full Text] [Related]
4. Central lymph nodes in frozen sections can effectively guide extended lymph node resection for papillary thyroid carcinoma. Peng L; Zheng X; Xue Y; Huang C; Su X; Yu S Ann Med; 2023; 55(2):2286337. PubMed ID: 38061392 [TBL] [Abstract][Full Text] [Related]
5. Patterns of Occult Metastasis to Level Va and Vb in Clinically Lateral Node-Positive Papillary Thyroid Carcinoma. Song K; Jin Y; Kim M; Moon S; Heo DB; Won HR; Chang JW; Koo BS Ann Surg Oncol; 2022 Apr; 29(4):2550-2556. PubMed ID: 34792697 [TBL] [Abstract][Full Text] [Related]
6. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients. Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891 [TBL] [Abstract][Full Text] [Related]
7. The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma. Jeon MJ; Yoon JH; Han JM; Yim JH; Hong SJ; Song DE; Ryu JS; Kim TY; Shong YK; Kim WB Eur J Endocrinol; 2013 Feb; 168(2):219-25. PubMed ID: 23161752 [TBL] [Abstract][Full Text] [Related]
8. Level I lymph node involvement in patients with N1b papillary thyroid carcinoma: a prospective study. Eweida AM; Sakr MF; Hamza Y; Khalil MR; Gabr E; Koraitim T; Al-Wagih HF; Abo-Elwafa W; Ezzat Abdel-Aziz T; Diab AA; El-Sabaa B; Nabawi AS Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1951-1958. PubMed ID: 27999997 [TBL] [Abstract][Full Text] [Related]
9. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma. Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178 [TBL] [Abstract][Full Text] [Related]
10. Should Level V Be Routinely Dissected in N1b Papillary Thyroid Carcinoma? Kim SK; Park I; Hur N; Lee JH; Choe JH; Kim JH; Kim JS Thyroid; 2017 Feb; 27(2):253-260. PubMed ID: 27762727 [TBL] [Abstract][Full Text] [Related]
11. Pattern of and clinicopathologic risk factors for lateral lymph node metastases in papillary thyroid carcinoma patients with lateral cervical lymphadenopathy. Gong Y; Yang J; Yan S; Su A; Liu F; Gong R; Zhu J; Li Z Medicine (Baltimore); 2018 Sep; 97(36):e12263. PubMed ID: 30200164 [TBL] [Abstract][Full Text] [Related]
12. Indications of Superselective Neck Dissection in Patients With Lateral Node Metastasis of Papillary Thyroid Carcinoma. Song Y; Xu G; Wang T; Zhang Y; Zhang B Otolaryngol Head Neck Surg; 2022 May; 166(5):832-839. PubMed ID: 34488520 [TBL] [Abstract][Full Text] [Related]
13. Analysis of factors influencing cervical lymph node metastasis of papillary thyroid carcinoma at each lateral level. Liu WQ; Yang JY; Wang XH; Cai W; Li F BMC Surg; 2022 Jun; 22(1):228. PubMed ID: 35701785 [TBL] [Abstract][Full Text] [Related]
14. Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1-2 Central Lymph Node Metastases. Wang Y; Deng C; Shu X; Yu P; Wang H; Su X; Tan J Front Endocrinol (Lausanne); 2021; 12():716728. PubMed ID: 34721289 [TBL] [Abstract][Full Text] [Related]
15. Level II lateral neck dissection for papillary thyroid carcinoma: A retrospective cohort study. Lv T; Ma WL; Tan Z; Jiang LH; Liang JY; Wu JJ; Hou CJ; Ge MH; Wang JF Asian J Surg; 2023 Oct; 46(10):4290-4295. PubMed ID: 37085417 [TBL] [Abstract][Full Text] [Related]
16. Lateral lymph node metastasis in papillary thyroid cancer: Is there a difference between PTC and PTMC? Ma W; Guo Y; Hua T; Li L; Lv T; Wang J Medicine (Baltimore); 2024 Apr; 103(17):e37734. PubMed ID: 38669400 [TBL] [Abstract][Full Text] [Related]
17. [Lateral neck lymph node metastasis in cN0 papillary thyroid carcinoma]. Chen R; Wei T; Zhang M; Li JQ; Zou XH; Fu BH; Wang LP; Peng YL; Ma BY; Zhu JQ Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 47(8):662-7. PubMed ID: 23141398 [TBL] [Abstract][Full Text] [Related]
18. Significance of multifocality in papillary thyroid carcinoma. Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090 [TBL] [Abstract][Full Text] [Related]
19. Lymph node ratio as a tool to stratify patients with N1b papillary thyroid cancer. Luo Z; Hei H; Qin J; Zheng C; Gong W; Zhou B Langenbecks Arch Surg; 2023 Aug; 408(1):315. PubMed ID: 37584830 [TBL] [Abstract][Full Text] [Related]
20. How Many Nodes to Take? Lymph Node Ratio Below 1/3 Reduces Papillary Thyroid Cancer Nodal Recurrence. Weitzman RE; Justicz NS; Kamani D; Kyriazidis N; Chen MH; Randolph GW Laryngoscope; 2022 Sep; 132(9):1883-1887. PubMed ID: 35229306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]